Quanterix (QTRX) Receivables - Other (2017 - 2023)

Quanterix (QTRX) reported Receivables - Other of $100000.0 for Q1 2023, little changed on a YoY basis from $100000.0 in Q1 2022, and down 50.0% quarter-over-quarter from $200000.0 in Q3 2022.

Quanterix (QTRX) Receivables - Other (2017 - 2023) Analysis & Trends

Quanterix has reported Receivables - Other for 7 years, with the latest figure at $100000.0 in Q1 2023.

  • For the quarter ending Q1 2023, Receivables - Other changed 0.0% year-over-year to $100000.0; the trailing twelve-month figure through Mar 2023 stood at $100000.0 (changed 0.0% YoY), and the FY2021 full-year result was $200000.0, up 16.28% from the prior year.
  • Receivables - Other for Q1 2023 stood at $100000.0, down from $200000.0 in the prior quarter.
  • The five-year high for Receivables - Other was $321000.0 in Q3 2019, with the low at $23000.0 in Q1 2019.
  • Historically, Receivables - Other has averaged $143000.0 across 5 years, with a median of $135500.0 in 2021.
  • The largest YoY upside for Receivables - Other was 1683.33% in 2019 against a maximum downside of 87.63% in 2019.
  • Quanterix's Receivables - Other stood at $186000.0 in 2019, then fell by 7.53% to $172000.0 in 2020, then climbed by 16.28% to $200000.0 in 2021, then changed by 0.0% to $200000.0 in 2022, then slumped by 50.0% to $100000.0 in 2023.
  • The last three Receivables - Other figures came in at $100000.0 (Q1 2023), $200000.0 (Q3 2022), and $100000.0 (Q1 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Quanterix 159.26 Mn 59.99 Mn 15.57 Mn

Historic Data

Download Data
DateValue
Mar 31, 2023 100,000.00
Mar 31, 2023 100,000.00
Sep 30, 2022 200,000.00
Sep 30, 2022 200,000.00
Mar 31, 2022 100,000.00
Mar 31, 2022 100,000.00
Dec 31, 2021 200,000.00
Dec 31, 2021 200,000.00
Sep 30, 2021 170,000.00
Sep 30, 2021 170,000.00
Jun 30, 2021 134,000.00
Jun 30, 2021 134,000.00
Mar 31, 2021 137,000.00
Mar 31, 2021 137,000.00
Dec 31, 2020 172,000.00
Dec 31, 2020 172,000.00
Sep 30, 2020 73,000.00
Sep 30, 2020 73,000.00
Mar 31, 2020 91,000.00
Mar 31, 2020 91,000.00